2,281 posters, 63 videos, 56 audios, 43 topics, 18 sessions, 6,174 authors, 2,323 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
RCOG World Congress 2025
June 23 - 25, 2025 | ExCeL London, UK
EP.1657
Severe Pre eclampsia complicated with acute pulmonary oedema and postnatal HELLP syndrome
Poster Presenter
Part of Topic
Maternal medicine
One right decision saves two lives : Severe pre eclampsiacomplicated by acute pulmonary oedema and postnatal HELLP syndrome
Dr. KhinKhin YuMaw, Specialist Registrar Obstetrics and Gynaecology, Dr. AselaDassanayake, Specialitst Registrar Obstetrics and Gynaecology,
Mr Adam Brook, Consultant Obstetrician Gynaecologist, Miss Natalie Smith, Consultant Obstetrician Gynaecologist
Scarborough General Hospital, York and Scarborough Hospital NHS Trust
Objective
Pre eclampsia (PET) is a common condition, rarely leading to serious life threatening sequelae.
We present an unusual case complicated by acute pulmonary oedema leading to delivery with rapid onset of postnatal HELLP syndrome.
Case Report
A 27 years old G2P0+1 diagnosed with moderate PET developed spontaneous acute pulmonary oedema and rapid onset of postnatal HELLP syndrome (haemolysis, elevated liver enzymes, low platelets) .
Background
•Fetal growth scan performed at 26 weeks following reduced fetal movements revealing fetal growth restriction (<10thcentile) with umbilical artery Doppler >95% centile.
•At 31 weeks, protein-creatinine ratio 41mg/mmol (positive). BP >140/90mmHg; labetalol and nifedipine started.
•Further reduction in fetal growth (4.6thcentile) occurred, umbilical artery Doppler PI remained >95% centile consistent with fetal growth restriction.
Discussion
Early severe PET (<32 weeks) is associated with high risk of maternal mortality and perinatal compromise. Maternal mortality as high as 20 fold.1 This case highlights the following learning points:
•Although many women may often be asymptomatic, especially in the initial stages, a high index of suspicion is needed with close surveillance to allow early detection of evolving complications, particularly subtle biochemical progression.
•Clinical situations can change drastically; deterioration and decompensation can be fulminant.
Conclusion
•Prediction, prevention and appropriate early treatment of women developing a severe pattern of disease is pertinent in reducing both maternal and perinatal morbidity and mortality.
